child_psychiatry | CARLAT PUBLISHING

EXPERT Q&A

Cultural Issues in Child and Adolescent Psychiatry

August 5, 2020

Andres Pumariega, MD
Professor and Chief, Division of Child and Adolescent Psychiatry, Department of Psychiatry, University of Florida, Gainesville, FL Dr. Pumariega has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Read our interview with Dr. Andres Pumariega, MD. Professor and Chief, Division of Child and Adolescent Psychiatry in the Department of Psychiatry at University of Florida, Gainesville, FL, who offers truly sage and actionable advice about how to approach, understand and address issues of culture and diversity in child and adolescent psychiatry.

Note From the Editor-in-Chief

February 11, 2020

Joshua D. Feder, MD

Joshua D. Feder, MD

It is hard to put into words what it was like talking with Russ Barkley and Ned Hallowell for this issue on ADHD. I hope that when you read these two interviews, you will experience my joy at spending time with these masters in the field.

Highlights From This Issue

February 11, 2020

Quick summary of what you’ll learn.

Note From the Editor-in-Chief

November 21, 2019

Joshua D. Feder, MD

Joshua D. Feder, MD

Welcome to the final 2019 issue of the Carlat Child Psychiatry Report. Our theme for this issue is autism, and we have a number of insights to share.

Note From the Editor-in-Chief

October 3, 2019

This issue will help you assess and manage substance use disorders in teens. It features interviews with cutting-edge people. The issue also discusses assessment, treatment planning, and prevention for children and teens at risk for suicide.

Note From the Editor-in-Chief

June 26, 2019

Joshua Feder, MD

Joshua Feder, MD

In this double issue, we tackle a range of questions. First, does TMS help kids and teens with depression? Is it safe? Since many clinics are advertising TMS, we thought it was worth a close look.

Medications for Depression

June 11, 2019

Martha J. Ignaszewski, MD

Martha J. Ignaszewski, MD

Chief Fellow, Clinical Fellow in Psychiatry at Boston Children’s Hospital

Dr. Ignaszewski has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In this QA, we review the findings of placebo- controlled trials done over the past 10 years on depression in kids and the discuss the current recommendations for medication treatment of depression in children and adolescents.

FDA Approves Adhansia XR

June 11, 2019

Talia Puzantian, PharmD, BCPP and Joshua Feder, MD

Talia Puzantian, PharmD, BCPP Joshua Feder, MD Drs. Puzantian and Feder have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In this article we discuss a newly FDA-approved formulation for ADHD. Adhansia XR, is a new formulation of extended-release methylphenidate approved by the FDA for the treatment of ADHD in patients 6 years and older.

First Non-Drug Treatment Approved by FDA for Treating Children With ADHD

June 11, 2019

Talia Puzantian, PharmD, BCPP and Joshua Feder, MD

Talia Puzantian, PharmD, BCPP Joshua Feder, MD Drs. Puzantian and Feder have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In the article we discuss the effectiveness and safety of the first non-drug treatment for ADHD in kids. The FDA has recently granted medical device approval for its external Monarch Trigeminal Nerve Stimulation (eTNS) System for treating kids with ADHD ages 7–12 who are not currently taking medications.

Prescribing Patterns for Children With Anxiety Disorders

June 11, 2019

Pavan Madan, MD.

Pavan Madan, MD. Dr. Madan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Anxiety disorders are some of the most common conditions we encounter in children and adolescents, and clinicians employ a variety of medications to treat them. This study examined prescribing patterns for the initial treatment of pediatric anxiety.